fda - Search News

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

FDA approves new pain medication as an alternative to opioids: What to know about Journavx

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

Newsweek on MSN · 3h

What is Non-Opioid Pain Medication? Journavx Approved by FDA

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

Hosted on MSN · 3h

FDA OK's painkiller designed to end opioids' addiction and overdose risk

Federal officials approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.

Ozempic receives FDA nod for treating chronic kidney disease

CNN on MSN · 2d

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,

U.S. News & World Report · 2d

FDA Approves Ozempic to Protect Kidneys in Patients With Type 2 Diabetes

Doctors already use Ozempic to manage type 2 diabetes and reduce the risk of heart disease in patients with diabetes. This move, as reported by The Times, was based on research sh

Hosted on MSN · 1d

Ozempic receives FDA nod for treating chronic kidney disease; experts explain how diabetes drug reduces CKD risk

The US Food and Drug Administration (FDA) approval is based on the clinical trials that showed how Ozempic, the diabetes drug, showed a reduced risk of kidney failure. Experts explain how the drug helps.

FDA issues Class I on Lay's potato chips

Newsweek on MSN · 2d

Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States

A recall which was issued across nine states has now been given the highest risk classification by the federal agency.

Fortune on MSN · 2d

FDA reclassifies Lay’s potato chips recall to the highest risk level, warning the chips could cause ‘serious adverse health consequences or death’

The FDA has raised the risk level on a recall of Lay’s potato chips to the highest level, warning the recalled product could cause death. The chips were originally recalled last month for containing undeclared milk.

Austin American-Statesman on M… · 2d

Put down the bag of chips: FDA issues Class I on Lays potato chips for undeclared allergen

According to the FDA, If consumers have an allergy or sensitivity to milk, they should not consume the product and discard it immediately.

21h

US FDA Identifies Cybersecurity Risks in Certain Patient Monitors

(Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks ...

clickondetroit.com45m

Child killed in hyperbaric chamber explosion at Oakland County healthcare facility

A 5-year-old boy from Royal Oak was killed in an explosion while receiving hyperbaric oxygen therapy at a healthcare facility ...

Chocolate recall: Feds sound alarm on potentially deadly treats

A chocolate recall was recently upgraded to warn consumers of a potential to “cause serious adverse health consequences of death.” ...

Cowboys QB Dak Prescott supports effort to get cancer test covered by Medicare

Bill to pay for multi-cancer early detection screening test has bipartisan support, but just ran out of time last session.

Daily Meal on MSN50m

The Pretzel Snack That Was Just Recalled Over An Undeclared Allergen

It's time, yet again, to check your pantries for a recalled food item. This one is a snack-worthy pretzel that may have found ...

Healio23m

Top in allergy/asthma: ‘Psychosocial burden’ of food allergy; peanut allergy patch

Regardless of sociodemographic or clinical characteristics, children with food allergy face a significant psychosocial burden ...

Bill McEwen16m

About Half of Americans Approve of Using Weight-Loss Drugs to Treat Obesity, Poll Finds

New poll reveals Americans' mixed views on weight-loss drugs for obesity treatment, especially regarding teen use.

2025 Medical Device Cybersecurity Trends: What Will Shape The Industry?

What will the industry face or achieve in 2025? These trends will be critical in medical device cybersecurity.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

Ozempic receives FDA nod for treating chronic kidney disease

FDA issues Class I on Lay's potato chips

Related topics